Osiris Therapeutics, Inc. (Nasdaq: OSIR) issued a statement correcting certain inaccuracies in media reports following the announcement of its favorable ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE